Complex regional pain syndrome (CRPS)
Neuropathic pain · C8 · Reviewed by a board-certified pain physician on October 31, 2026
Bottom line
CRPS is a clinical diagnosis made with the Budapest criteria. Treatment centers on graded functional restoration; drugs, sympathetic blocks, ketamine and neuromodulation support rehabilitation rather than replace it.
Key points
- Diagnose with the Budapest clinical criteria. Continuing pain disproportionate to the inciting event, at least one symptom in three of four categories (sensory, vasomotor, sudomotor/edema, motor/trophic), at least one sign in two or more categories, and no better explanation. Imaging and blocks are not required for the diagnosis 1.
- Functional restoration is the core. The 5th-edition guidelines center care on graded physical and occupational therapy. Sympathetic blocks, drugs and psychotherapy are used mainly when progress stalls or pain blocks engagement 2.
- Bisphosphonates: modest and short-lived. A 2026 meta-analysis found that bisphosphonates may reduce pain at 1 to 3 months (about 10 points on a 100-point scale, low certainty), with little or no medium-term difference and more adverse events 3.
- Ketamine infusions have moderate support. The chronic pain ketamine consensus found moderate evidence for CRPS, with improvement lasting up to 12 weeks; avoid it in poorly controlled cardiovascular disease or psychosis and severe hepatic impairment 4.
- DRG stimulation for focal lower-limb CRPS. In ACCURATE, 81.2% treatment success with dorsal root ganglion stimulation versus 55.7% with tonic spinal cord stimulation at 3 months, with more targeted coverage 5.
- Children: exercise therapy plus psychology. Exercise and physical therapy are the cornerstones of pediatric CRPS, within an interdisciplinary program with CBT; invasive treatments have only weak evidence 62.
Watch for
Immobilization perpetuates CRPS: casting healthy volunteers for 28 days produced CRPS-like signs, so rest and disuse should be reversed, not prescribed 2.
High-yield for the exam
- Budapest clinical criteria kept the IASP criteria's sensitivity (0.99) and improved specificity (0.68); the research criteria are more specific (0.79) 1.
- Signs must be observed on examination in at least two categories 1.
- Graded motor imagery has mixed trial results; functional restoration is the consistent core 2.
- Bisphosphonates probably increase adverse events (risk ratio 1.1, moderate certainty) 3.
- ACCURATE enrolled lower-extremity CRPS only, so it does not support upper-limb DRG use 5.
- In children, PT plus CBT improved pain and function in a randomized trial, with sustained benefit in most 2.
Numbers to know
| Item | Value |
|---|---|
| Budapest clinical symptom categories | ≥3 of 4 1 |
| Budapest sign categories | ≥2 of 4 1 |
| ACCURATE treatment success at 3 months | 81.2% DRG vs 55.7% SCS 5 |
| ACCURATE trial size | 152 patients 5 |
| Ketamine benefit in CRPS | up to 12 weeks 4 |
| Budapest clinical criteria sensitivity / specificity | 0.99 / 0.68 1 |
| Bisphosphonate short-term pain effect | about −10/100, low certainty 3 |
Common traps
- Waiting for pain to settle before starting graded therapy 2.
- Requiring imaging or a sympathetic block response to make the diagnosis; Budapest criteria are clinical 1.
- Calling bisphosphonates a cure or durable treatment 3.
- Offering a sympathetic block or a stimulator trial in place of rehabilitation rather than to enable it 2.
Practise this topic
5 more questions on this topic in the full question bank, with explanations and sources.
Sources
- Harden NR, et al. Validation of proposed diagnostic criteria (the "Budapest Criteria") for complex regional pain syndrome. Pain, 2010. pmc.ncbi.nlm.nih.gov/articles/PMC2914601/
- Harden RN, et al. Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 5th Edition. Pain Med, 2022. pmc.ncbi.nlm.nih.gov/articles/PMC9186375/
- Ferraro MC, et al. Efficacy and safety of bisphosphonates for complex regional pain syndrome: a systematic review and meta-analysis. Ann Intern Med, 2026. pubmed.ncbi.nlm.nih.gov/41397259/
- Cohen SP, et al. Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists. Reg Anesth Pain Med, 2018. pmc.ncbi.nlm.nih.gov/articles/PMC6023575/
- Deer TR, et al. Dorsal root ganglion stimulation yielded higher treatment success rate for complex regional pain syndrome and causalgia at 3 and 12 months: a randomized comparative trial. Pain, 2017. pmc.ncbi.nlm.nih.gov/articles/PMC5359787/
- Weissmann R, Uziel Y. Pediatric complex regional pain syndrome: a review. Pediatr Rheumatol Online J, 2016. pmc.ncbi.nlm.nih.gov/articles/PMC4850724/
Related topics
Independent study material for the ABA Pain Medicine exam, written and reviewed by a board-certified pain physician. Not medical advice; not affiliated with the American Board of Anesthesiology.